NCT01256905View on ClinicalTrials.gov

Attention Modulation for Treatment of Parkinson's Disease and Dementia With Lewy Bodies

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 1, 2011

Primary Completion Date

August 8, 2011

Study Completion Date

August 8, 2011

Conditions
Parkinsons DiseaseLewy Bodies Disease
Interventions
DRUG

Armodafinil

Armodafinil 150 mg

Trial Locations (1)

10016

NYU Parkinsons and Movement Disorders Center, New York

Sponsors

Collaborators (1)

Cephalon
All Listed Sponsors
collaborator

Cephalon

INDUSTRY

lead

NYU Langone Health

OTHER